Healthy Volunteers Needed

NIAID researchers seek healthy volunteers, 18-60 years old, for a study at the Clinical Center to examine safety and tolerability of an investigational product targeting Ebola. You cannot get Ebola from this product. Financial compensation is provided. For more information, call 1-866-444-2214 (TTY 1-866-411-1010). Read more at https://clinicaltrials.gov/ct2/show/NCT03478891.

People with Anxiety Sought

NIMH is studying people with anxiety and how they respond to stressful events. Researchers are seeking those with general anxiety, panic and/or social anxiety disorder. Study requires 1 to 2 outpatient visits to the Clinical Center. Compensation will be provided. For more information, call 1-866-444-2214 (TTY 1-866-411-1010) and refer to study 03-M-0093.

Vaccine Study Seeks Healthy Vols

Researchers at NIAID’s Vaccine Research Center need healthy volunteers 18-60 who are living with HIV for a research study. The study evaluates an investigational product targeting the HIV virus to determine if it is safe and can generate an immune response. Compensation is provided. For more information call the Office of Patient Recruitment at 1-866-444-2214 (TTY 1-866-411-1010) or email vaccines@nih.gov. Se habla español. Refer to study 18-I-0030.

Stress Study Recruits Volunteers

NIMH is studying how the brain and body respond to stressful events. Researchers are seeking healthy volunteers without mental health disorders. Study requires four outpatient visits to the Clinical Center. Compensation will be provided. For more information, call (301) 402-4961 (TTY 1-866-411-1010) and refer to study 17-M-0046.

RSV Challenge Study Looking for Healthy Volunteers

NIAID researchers are seeking healthy volunteers, 18-50 years old, to participate in a respiratory syncytial virus (RSV) challenge study at the Clinical Center. Participants will receive one dose of the RSV virus. Afterwards they will be required to stay in the hospital from 9 to 16 days or more and return for follow-up visits about 1 and 2 months after infection. They may develop mild or medium cold symptoms. Researchers will use what they learn to test new antivirals to treat and vaccines to prevent RSV in the future. Compensation is provided. For more information, call 1-866-444-2214 (TTY 1-866-411-1010) or go online to https://go.usa.gov/xnpZD.